Overland ADCT BioPharma Appoints Eric Koo As Chief Executive Officer >ADCT
3 Stocks At 52-Week Lows That Could Bounce Big
ADC Therapeutics Price Target Cut to $55.00/Share From $56.00 by Morgan Stanley
ADC Therapeutics analyst ratings
Morgan Stanley Maintains Overweight on ADC Therapeutics, Lowers Price Target to $55
12 Health Care Stocks Moving In Friday's Pre-Market Session
ADC Therapeutics Is Maintained at Buy by HC Wainwright & Co.
ADC Therapeutics analyst ratings
HC Wainwright & Co. Maintains Buy on ADC Therapeutics, Raises Price Target to $48
BRIEF-ADC Therapeutics Reports Fourth Quarter And Year-End 2020 Results